NOTCH3 and Alzheimer disease: To directly target the NOTCH3 ECD aggregation, it may therefore be interesting to explore an active immunization strategy, a therapeutic strategy which has been proven safe in several AD trials with different vaccines targeting Aβ (Vandenberghe et al, 2017; Novak et al, 2019; Rosenberg & Lambracht‐Washington, 2020).